[1]
G. Pancevski, S. Pepic, S. Idoska, G. Tofoski, and S. Nikolovska, “Topical Imiquimod 5% as a Treatment Option in Solitary Facial Keratoacanthoma”, Open Access Maced J Med Sci, vol. 6, no. 3, pp. 531–535, Mar. 2018.